Dynavax Technologies Q3 EPS $0.10, Sales $69.51M Beat $60.30M Estimate
Portfolio Pulse from Benzinga Newsdesk
Dynavax Technologies reported Q3 earnings of $0.10 per share, beating the analyst consensus estimate of $(0.01) by 1100 percent. This is a 76.74 percent decrease from last year. The company also reported quarterly sales of $69.51 million, beating the analyst consensus estimate of $60.30 million by 15.28 percent, but a 58.56 percent decrease from last year.
November 02, 2023 | 9:33 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Dynavax's Q3 earnings and sales beat estimates but are significantly lower than last year's figures.
While Dynavax's Q3 earnings and sales beat analyst estimates, they are significantly lower than the same period last year. This mixed result could lead to neutral short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100